NeilMed Pharmaceuticals
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
33%
2 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Manuka Honey Nasal Rinse Study
Role: collaborator
Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
Role: collaborator
SinuSurf vs. Saline Solution in Normal Subjects
Role: collaborator
Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms
Role: collaborator
Saline Irrigation After Surgery in Patients With Chronic Sinusitis
Role: collaborator
The Impact of Daily Sinus Irrigation on Nasal Symptoms in Continuous Positive Airway Pressure (CPAP) Users - A Pilot Study
Role: collaborator
All 6 trials loaded